Another bioinformatical analysis was performed on pancreatic adenocarcinoma by Duan et al., who presented the correlation between PHLDA1 expression and sensitivity to chemotherapeutic and targeted drugs used to treat pancreatic adenocarcinoma (Duan et al. 2022). This evidence concerns the gene PHLDA1 and pancreatic adenocarcinoma.